• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

谷氨酸转运蛋白 SLC1A1 与肾透明细胞癌相关。

Glutamate transporter SLC1A1 is associated with clear cell renal cell carcinoma.

出版信息

Turk J Med Sci. 2019 Apr 18;49(2):531-537. doi: 10.3906/sag-1808-130.

DOI:10.3906/sag-1808-130
PMID:30862152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7024430/
Abstract

BACKGROUND/AIM: This study aimed to comparatively analyze the expression levels of the SLC1A1 gene in renal specimens from tumors and adjacent healthy kidney tissues of patients with clear cell renal cell carcinoma (ccRCC).

MATERIALS AND METHODS

Nineteen patients diagnosed with ccRCC were included in the study. The expression levels of the SLC1A1 and GAPDH genes were measured in tumor and formalin-fixed paraffin-embedded (FFPE) tissue specimens from the adjacent healthy kidney of each subject. Via the GEPIA database, the distribution of SLC1A1 gene expressions in ccRCC and healthy kidney tissues was obtained. The relative expression of SLC1A1 was evaluated for the association with the clinical parameters of the patients.

RESULTS

The expression of the SLC1A1 gene was significantly higher in males than females (P = 0.029). Also, there were statistically significant associations between stages II–IV and Fuhrman grades 2–4 with respect to SLC1A1 gene expression (P < 0.001 for both). Moreover, low levels of red blood cell and hemoglobin counts were significantly associated with the SLC1A1 expression (P < 0.001 and P = 0.005, respectively). The expression of the SLC1A1 gene in tumor tissues increased approximately 3 times compared with normal kidney tissues (P < 0.05). According to the GEPIA database, SLC1A1 gene expression is significantly higher in ccRCC patients than healthy persons (P = 0.01).

CONCLUSION

The change in the expression of SLC1A1 may be crucial for ccRCC pathophysiology.

摘要

背景/目的:本研究旨在比较分析透明细胞肾细胞癌(ccRCC)患者肿瘤组织和相邻正常肾组织中 SLC1A1 基因的表达水平。

材料和方法

纳入 19 例经诊断为 ccRCC 的患者。测量每位患者肿瘤和相邻正常肾组织福尔马林固定石蜡包埋(FFPE)组织标本中 SLC1A1 和 GAPDH 基因的表达水平。通过 GEPIA 数据库获得 SLC1A1 基因在 ccRCC 和正常肾组织中的表达分布。评估 SLC1A1 的相对表达与患者临床参数的相关性。

结果

SLC1A1 基因的表达在男性中显著高于女性(P = 0.029)。此外,SLC1A1 基因的表达与 II-IV 期和 Fuhrman 分级 2-4 之间存在统计学显著相关性(均 P < 0.001)。此外,红细胞和血红蛋白计数低与 SLC1A1 表达显著相关(均 P < 0.001 和 P = 0.005)。与正常肾组织相比,肿瘤组织中 SLC1A1 基因的表达增加了约 3 倍(P < 0.05)。根据 GEPIA 数据库,SLC1A1 基因在 ccRCC 患者中的表达明显高于健康人(P = 0.01)。

结论

SLC1A1 表达的变化可能对 ccRCC 发病机制至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b7/7024430/19e34abb0b0b/turkjmedsci-49-531-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b7/7024430/887871db285f/turkjmedsci-49-531-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b7/7024430/b7d6a4812a8c/turkjmedsci-49-531-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b7/7024430/19e34abb0b0b/turkjmedsci-49-531-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b7/7024430/887871db285f/turkjmedsci-49-531-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b7/7024430/b7d6a4812a8c/turkjmedsci-49-531-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b7/7024430/19e34abb0b0b/turkjmedsci-49-531-fig003.jpg

相似文献

1
Glutamate transporter SLC1A1 is associated with clear cell renal cell carcinoma.谷氨酸转运蛋白 SLC1A1 与肾透明细胞癌相关。
Turk J Med Sci. 2019 Apr 18;49(2):531-537. doi: 10.3906/sag-1808-130.
2
Expression of miRNA-21 and miRNA-221 in clear cell renal cell carcinoma (ccRCC) and their possible role in the development of ccRCC.miRNA-21和miRNA-221在肾透明细胞癌(ccRCC)中的表达及其在ccRCC发生发展中的可能作用。
Urol Oncol. 2016 Dec;34(12):533.e21-533.e27. doi: 10.1016/j.urolonc.2016.06.011. Epub 2016 Jul 15.
3
Transcriptome Sequencing (RNAseq) Enables Utilization of Formalin-Fixed, Paraffin-Embedded Biopsies with Clear Cell Renal Cell Carcinoma for Exploration of Disease Biology and Biomarker Development.转录组测序(RNAseq)能够利用福尔马林固定、石蜡包埋的透明细胞肾细胞癌活检组织来探索疾病生物学并开发生物标志物。
PLoS One. 2016 Feb 22;11(2):e0149743. doi: 10.1371/journal.pone.0149743. eCollection 2016.
4
MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma.微小 RNA-15a 在组织中的表达是透明细胞肾细胞癌患者生存的预后标志物。
Clin Exp Med. 2019 Nov;19(4):515-524. doi: 10.1007/s10238-019-00574-7. Epub 2019 Aug 22.
5
High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.P53 诱导的环指蛋白 2 高表达与肾透明细胞癌患者预后不良相关。
Eur J Surg Oncol. 2013 Jan;39(1):100-6. doi: 10.1016/j.ejso.2012.10.004. Epub 2012 Oct 24.
6
Expanding the Utilization of Formalin-Fixed, Paraffin-Embedded Archives: Feasibility of miR-Seq for Disease Exploration and Biomarker Development from Biopsies with Clear Cell Renal Cell Carcinoma.扩大福尔马林固定、石蜡包埋存档的应用:miR-Seq 用于透明细胞肾细胞癌活检的疾病探索和生物标志物开发的可行性。
Int J Mol Sci. 2018 Mar 10;19(3):803. doi: 10.3390/ijms19030803.
7
The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma.两个糖酵解标志物 GLUT1 和 MCT1 与透明细胞肾细胞癌的肿瘤分级和生存相关。
PLoS One. 2018 Feb 26;13(2):e0193477. doi: 10.1371/journal.pone.0193477. eCollection 2018.
8
DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.DKC1 可作为人肾透明细胞癌的潜在预后生物标志物,通过 NF-κB 通路促进其增殖、迁移和侵袭。
Oncol Rep. 2018 Aug;40(2):968-978. doi: 10.3892/or.2018.6484. Epub 2018 Jun 11.
9
Global analysis of metastasis-associated gene expression in primary cultures from clinical specimens of clear-cell renal-cell carcinoma.对来自透明细胞肾细胞癌临床标本的原代培养物中转移相关基因表达的全局分析。
Int J Cancer. 2008 Sep 1;123(5):1080-8. doi: 10.1002/ijc.23637.
10
RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma.RAC2 可作为一种预后生物标志物,并促进肾透明细胞癌的进展。
Int J Oncol. 2019 Sep;55(3):645-656. doi: 10.3892/ijo.2019.4849. Epub 2019 Jul 26.

引用本文的文献

1
Expression Analysis of Cyst Specific Protein (CSP21) and Cellulose Synthase II (CSII) Genes in Acanthamoeba castellanii Trophozoites Exposed to Silver Nanoparticles Conjugated with Elaeagnus umbellata.暴露于胡颓子叶缀合的银纳米颗粒的卡氏棘阿米巴滋养体中囊肿特异性蛋白(CSP21)和纤维素合酶II(CSII)基因的表达分析
Acta Parasitol. 2025 Jan 6;70(1):5. doi: 10.1007/s11686-024-00947-3.
2
Adaptive and non-adaptive gene expression responses in prostate cancer during androgen deprivation.雄激素剥夺治疗期间前列腺癌中的适应性和非适应性基因表达反应
PLoS One. 2023 Feb 21;18(2):e0281645. doi: 10.1371/journal.pone.0281645. eCollection 2023.
3

本文引用的文献

1
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.GEPIA:一个用于癌症和正常基因表达谱分析及交互式分析的网络服务器。
Nucleic Acids Res. 2017 Jul 3;45(W1):W98-W102. doi: 10.1093/nar/gkx247.
2
Renal cell carcinoma: new insights and challenges for a clinician scientist.肾细胞癌:临床科学家面临的新见解与挑战
Am J Physiol Renal Physiol. 2017 Aug 1;313(2):F145-F154. doi: 10.1152/ajprenal.00480.2016. Epub 2017 Apr 5.
3
The epigenetic landscape of clear-cell renal cell carcinoma.透明细胞肾细胞癌的表观遗传格局
Comprehensive analyses of the microRNA-messenger RNA-transcription factor regulatory network in mouse and human renal fibrosis.
小鼠和人类肾纤维化中微小RNA-信使核糖核酸-转录因子调控网络的综合分析
Front Genet. 2022 Nov 15;13:925097. doi: 10.3389/fgene.2022.925097. eCollection 2022.
4
Comprehensive Analysis of Potential Correlation Between Solute Carrier 1A (SLC1A) Family and Lung Adenocarcinoma.溶质载体1A(SLC1A)家族与肺腺癌潜在相关性的综合分析
Int J Gen Med. 2022 Feb 24;15:2101-2117. doi: 10.2147/IJGM.S350986. eCollection 2022.
5
Identification of Prognostic Metabolism-Related Genes in Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌中预后相关代谢基因的鉴定
J Oncol. 2021 Sep 27;2021:2042114. doi: 10.1155/2021/2042114. eCollection 2021.
J Kidney Cancer VHL. 2015 May 28;2(3):90-104. doi: 10.15586/jkcvhl.2015.33. eCollection 2015.
4
Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients.当代患者中透明细胞肾细胞癌的分期、大小、分级及坏死(SSIGN)评分的应用
Eur Urol. 2017 Apr;71(4):665-673. doi: 10.1016/j.eururo.2016.05.034. Epub 2016 Jun 7.
5
Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathology.透明细胞肾细胞癌的表观基因组学:分子病理学中的机制及潜在应用
Chin J Cancer Res. 2016 Feb;28(1):80-91. doi: 10.3978/j.issn.1000-9604.2016.02.09.
6
1,25-Dihydroxyvitamin D induces the glutamate transporter SLC1A1 and alters glutamate handling in non-transformed mammary cells.1,25-二羟基维生素D诱导谷氨酸转运体SLC1A1并改变非转化乳腺细胞中的谷氨酸处理。
Mol Cell Endocrinol. 2016 Mar 15;424:34-41. doi: 10.1016/j.mce.2016.01.011. Epub 2016 Jan 14.
7
Renal cell carcinoma: histological classification and correlation with imaging findings.肾细胞癌:组织学分类及其与影像学表现的相关性
Radiol Bras. 2015 May-Jun;48(3):166-74. doi: 10.1590/0100-3984.2013.1927.
8
How should clinicians address intratumour heterogeneity in clear cell renal cell carcinoma?临床医生应如何应对透明细胞肾细胞癌中的肿瘤内异质性?
Curr Opin Urol. 2015 Sep;25(5):358-66. doi: 10.1097/MOU.0000000000000204.
9
Hypoxia-inducible factors enhance glutamate signaling in cancer cells.缺氧诱导因子增强癌细胞中的谷氨酸信号传导。
Oncotarget. 2014 Oct 15;5(19):8853-68. doi: 10.18632/oncotarget.2593.
10
Pure erythropoiesis in clear cell renal cell carcinoma.透明细胞肾细胞癌中的纯红细胞生成
Int J Surg Pathol. 2010 Dec;18(6):544-6. doi: 10.1177/1066896910376769. Epub 2010 Jul 28.